Genmab A/S logo

Genmab A/S

GMAB | NASDAQ
Chart Builder DCF Calculator
$34.69
-$0.05 (-0.14%)
At close: Sep 21, 2026, 4:00 PM ET
$34.48
-$0.21 (-0.61%)
Pre-market: Sep 22, 2026, 6:09 AM ET

Market Data

Market Cap
$21.33B
Enterprise Value
$25.07B
Beta
0.70
Average Volume
2.15M
Shares Outstanding (Diluted)
617.11M
Shares Change YoY
-0.45%
Institutional Ownership
13.33%
Exchange
NASDAQ
ISIN
US3723032062

Price Performance

Price Change 1M
5.6%
Price Change 3M
33.7%
Price Change 6M
32.9%
Price Change YTD
9.0%
Price Change 1Y
21.3%
Price Change 3Y
-3.9%
Price Change 5Y
-20.1%
1M CAGR (ann.)
16.5%
1Y CAGR (ann.)
23.7%
5Y CAGR (ann.)
-4.6%
All-Time CAGR
13.7%

Valuation

PE Ratio
27.31
Forward PE
19.11
PEG Ratio
-0.32
Forward PEG
0.60
PS Ratio
5.16
Forward PS
4.10
PB Ratio
3.58
P/FCF Ratio
24.55
P/Adj. FCF Ratio
26.74
P/OCF Ratio
23.76
EV/Sales
6.07
EV/EBIT
21.33
EV/EBITDA
20.56
EV/FCF
28.90
Earnings Yield
3.7%
FCF Yield
4.1%
Adj. FCF Yield
3.7%

Financial Health

Net Debt
$3.63B
Total Debt
$5.27B
Cash & Short-Term Investments
$1.5B
Total Assets
$12.52B
Current Ratio
2.46
Quick Ratio
2.44
Debt / Equity Ratio
0.89
Debt / EBITDA
4.32
Debt / FCF
6.08
OCF / Debt
0.17
Interest Coverage
4.98
Altman Z-Score
3.25
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
39.9%
Operating Profit Margin
32.3%
EBITDA Margin
14.4%
Net Profit Margin
8.2%
FCF Margin
21.0%
Adj. FCF Margin
19.3%
SBC / Revenue
1.6%
SBC Impact (per share)
-8.2%

Returns

Return on Assets
6.3%
Return on Equity
13.6%
Return on Invested Capital
9.9%
Return on Capital Employed
11.7%
Return on Tangible Assets
24.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
-36.6%
Revenue CAGR 5Y
-10.8%
Revenue CAGR 10Y
11.6%
EPS CAGR 3Y
-43.6%
EPS CAGR 5Y
-19.7%
EPS CAGR 10Y
1.1%
FCF CAGR 3Y
-46.4%
FCF CAGR 5Y
-31.2%
FCF CAGR 10Y
4.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
18
EPS Growth Next 3Y
26.6%
Revenue Growth Next 3Y
16.3%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
$16.66
Graham Upside
-52.0%
Lynch Fair Value
$6.35
Lynch Upside
-81.7%
Price Target
$38.25
Price Target Upside
10.3%

Cash Flow

Operating Cash Flow
$890.35M
Free Cash Flow
$867.34M
Adj. Free Cash Flow
$796.34M
FCF Per Share
$1.42
OCF Per Share
$1.46
OCF/S Ratio
9.3%

Income Statement

Revenue
$4.13B
Gross Profit
$3.84B
Operating Income
$1.33B
EBITDA
$1.22B
Net Income
$788.1M
EPS (Diluted)
$1.27
Revenue / Employee
$1.32M
Profit / Employee
$252.68K
Employees
3,119

© 2026 bestshares.com. All rights reserved.